Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

University of Pittsburgh School of Medicine, Pittsburgh

University of Pennsylvania, Philadelphia

Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), Fairfax

Duke University Medical Center, Durham

Emory University Hospital, Atlanta

University of Florida (UF) - Gainesville, Gainesville

Cincinnati Children's Hospital Medical Center, Cincinnati

Washington University in St. Louis, St Louis

University of California - Irvine Medical Center, Irvine

UZ Leuven, Leuven

Aarhus University Hospital, Aarhus

HCL Hopital Pierre Wertheimer, Bron

AP-HP Hopital Raymond Poincare, Garches

Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone, Marseille

CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires, Nice

Universitaetsklinikum Halle (Saale), Halle

SphinCS GmbH, Höchheim

Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München

"A.O.U. Policlinico G. Martino", Messina

AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino

Erasmus MC, GE Rotterdam

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitari i Politecnic La Fe, Valencia

Queen Elizabeth Hospital Birmingham, Birmingham

National Hospital for Neurology & Neurosurgery, London

Royal Free London NHS Foundation Trust, London

Royal Victoria Infirmary, Newcastle upon Tyne

Salford Royal Hospital, Salford